Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 20;e13632.
doi: 10.1111/dth.13632. Online ahead of print.

Covid-19 and Exacerbation of Psoriasis

Affiliations

Covid-19 and Exacerbation of Psoriasis

Resat Ozaras et al. Dermatol Ther. .

Similar articles

See all similar articles

References

REFERENCES

    1. Kutlu Ö, Metin A. A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: will cases of psoriasis increase after COVID-19 pandemic? Dermatol Ther. 2020;7:e13383. https://doi.org/10.1111/dth.13383.
    1. Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk factors for the development of psoriasis. Int J Mol Sci. 2019;20(18):4347.https://doi.org/10.3390/ijms20184347.
    1. Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020. https://doi.org/10.1515/cclm-2020-0369. [Online ahead of print].
    1. Ullah A, Zeb H, Khakwani Z, Murphy FT. Hydroxychloroquine-induced inverse psoriasis. BMJ Case Rep. 2019;12(2):e224619.
    1. Shindo E, Shikano K, Kawazoe M, et al. A case of generalized pustular psoriasis caused by hydroxychloroquine in a patient with systemic lupus erythematosus. Lupus. 2019 Jul;28(8):1017-1020. https://doi.org/10.1177/0961203319854139.

LinkOut - more resources

Feedback